Author:
Ku Lawrence C., ,Zimmerman Kanecia,Benjamin Daniel K.,Clark Reese H.,Hornik Christoph P.,Smith P. Brian
Funder
National Institute of Child Health and Human Development
National Institutes of Health
National Center for Advancing Translational Sciences
U.S. Food and Drug Administration
U.S. Department of Health and Human Services
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Pediatrics, Perinatology, and Child Health
Reference42 articles.
1. Dutertre JP, Billaud EM, Autret E, Chantepie A, Oliver I, Laugier J (1993) Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure. Br J Clin Pharmacol 35:528–530
2. Frenneaux M, Stewart RA, Newman CM, Hallidie-Smith KA (1989) Enalapril for severe heart failure in infancy. Arch Dis Child 64:219–223
3. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA (1991) Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 78:128–135
4. Mason T, Polak M, Pyles L, Mullett M, Swanke C (1992) Treatment of neonatal renovascular hypertension with intravenous enalapril. Am J Perinatol 9:254–257
5. BTA Pharmaceuticals, Inc. VASOTEC (enalapril maleate) tablet [updated June 2010].
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d181743-a0fc-4d17-953d-b17a936f9ecc
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献